Hyaluronic Acid Viscosupplementation | Medtech 360 | Market Analysis | Global | 2019
The global market for HA viscosupplementation will exhibit moderate growth through 2027. While premium-priced 1-injection products will continue to become more popular over the forecast period, 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil across a 10-year period.